Literature DB >> 11439732

Diagnosis and care of irritable bowel syndrome in a community-based population.

B P Yawn1, G R Locke, E Lydick, P C Wollan, S L Bertram, M J Kurland.   

Abstract

OBJECTIVE: To identify the healthcare utilization and evaluation in a community-based population with an incident diagnosis of irritable bowel syndrome (IBS). STUDY
DESIGN: Retrospective cohort. PATIENTS: A randomly selected cohort of 149 Olmsted County, MN, adults with an incident diagnosis of IBS between June 1, 1992, and December 31, 1994.
METHODS: Retrospective medical record review of each medical encounter for the 10 years before and the 3 years after the incident IBS diagnosis. Specific attention was given to healthcare visits, tests, and treatment associated with documented gastrointestinal (GI) tract symptoms and diagnosis of IBS.
RESULTS: Of 149 patients, 98 (66%) were women, and the mean patient age was 46.6 years. Patients averaged 4.7 healthcare visits annually, including 0.5 related to GI tract symptoms. Two thirds of patients had GI tract symptom-related visits at least 2 years before IBS diagnosis. Only 5% of IBS diagnoses were made by a gastroenterologist. Colon examinations (colonoscopy or barium enema) were performed on 47% of patients and were more common in those aged > or = 55 years (58% vs 36%; P = .02). One third of patients had no GI tract testing proximal to the IBS diagnosis. Following the IBS diagnosis, only about half the patients made any IBS or GI tract symptom-related visits per year.
CONCLUSION: The path to diagnosis of IBS is through the primary care physician and includes minimal testing and limited follow-up care.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439732

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  6 in total

1.  Diagnosing irritable bowel syndrome: what's too much, what's enough?

Authors:  Susan Lucak
Journal:  MedGenMed       Date:  2004-03-12

2.  Rational investigations in irritable bowel syndrome.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2019-06-06

Review 3.  Costs of irritable bowel syndrome in the UK and US.

Authors:  Stefanie Maxion-Bergemann; Frank Thielecke; Florian Abel; Rito Bergemann
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 4.  New developments in the diagnosis and treatment of irritable bowel syndrome.

Authors:  George F Longstreth; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 5.  Best management of irritable bowel syndrome.

Authors:  Christopher J Black; Alexander Charles Ford
Journal:  Frontline Gastroenterol       Date:  2020-05-28

6.  Knowledge and practices of primary care physicians or general practitioners treating post-infectious Irritable Bowel Syndrome.

Authors:  Erika Austhof; Kenzie Schaefer; Jaime Faulkner; Laura Bach; Mark Riddle; Kristen Pogreba-Brown
Journal:  BMC Gastroenterol       Date:  2020-05-25       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.